Expertise in
1
conditions

Dr. Shawn Searle

Family Medicine
Office
Salt Lake City, UT 
Expertise in
1
conditions
Office
Salt Lake City, UT 

Overview

Shawn Searle is a primary care provider, practicing in Family Medicine in Salt Lake City, Utah. Dr. Searle is highly rated in 1 condition, according to our data. His top areas of expertise are Phenylketonuria (PKU) and Alzheimer's Disease.

His clinical research consists of co-authoring 11 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Family Medicine

Licenses

Family Medicine in AZ

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

Office
Salt Lake City, UT 84106

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
A Single- and Multiple-Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Intravenous Doses of LY3002813 in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild to Moderate Alzheimer's Disease
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Biological, Drug
Study Phase: Phase 1
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
A Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacodynamics of SYNB8802 in Healthy Volunteers and in Patients With Enteric Hyperoxaluria
Enrollment Status: Completed
Publish Date: March 08, 2024
Intervention Type: Drug
Study Phase: Phase 1
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
An Open-label Study of the Efficacy and Safety of SYNB1618 and SYNB1934 in Patients With Phenylketonuria (SynPheny-1)
Enrollment Status: Completed
Publish Date: October 17, 2022
Intervention Type: Drug
Study Drug: SYNB1618
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Oral Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY3202328
A Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Oral Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY3202328
Enrollment Status: Completed
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 1
A Phase 1/2a, First-in-human, Oral Single and Multiple Dose-escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria to Evaluate Safety, Tolerability, Kinetics, and Pharmacodynamics
A Phase 1/2a, First-in-human, Oral Single and Multiple Dose-escalation, Randomized, Double-blinded, Placebo-controlled Study of SYNB1618 in Healthy Adult Volunteers and Adult Subjects With Phenylketonuria to Evaluate Safety, Tolerability, Kinetics, and Pharmacodynamics
Enrollment Status: Completed
Publish Date: May 13, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Single-Dose and Multiple-Dose, Dose-Escalation Study With LY2599666 to Evaluate the Safety, Pharmacokinetics, and Tolerability in Healthy Subjects and Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild-to-Moderate Alzheimer's Disease
Enrollment Status: Terminated
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Healthy Subjects and Patients With Alzheimer's Disease
A Single-Dose and Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3372993 in Healthy Subjects and Patients With Alzheimer's Disease
Enrollment Status: Completed
Publish Date: June 05, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 6 Less Clinical Trials

11 Total Publications

A Phase 1 Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy.
A Phase 1 Study to Evaluate the Pharmacokinetic Drug-Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy.
Journal: Clinical pharmacology in drug development
Published: May 17, 2024
Similar Doctors
Expertise in
33
conditions
Dr. Rohn Rigby
Family Medicine
Expertise in
33
conditions
Dr. Rohn Rigby
Family Medicine

Ogden Clinic Specialty Services

Ogden, UT 
 (547.5 miles away)
801-475-3800
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rohn Rigby is a primary care provider, practicing in Family Medicine in Ogden, Utah. Dr. Rigby is highly rated in 33 conditions, according to our data. His top areas of expertise are Mitochondrial Complex V Deficiency, Cytochrome C Oxidase Deficiency, Type B Insulin Resistance Syndrome, and Abdominal Obesity Metabolic Syndrome. Dr. Rigby is currently accepting new patients.

Preeti Murudkar
Expertise in
11
conditions
Dr. Preeti Murudkar
Family Medicine
Expertise in
11
conditions
Dr. Preeti Murudkar
Family Medicine

Imed Physicians

5121 S Cottonwood St, 
Murray, UT 
 (513.1 miles away)
801-507-3380
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Preeti Murudkar is a primary care provider, practicing in Family Medicine in Murray, Utah. Dr. Murudkar is highly rated in 11 conditions, according to our data. Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol. Dr. Murudkar is currently accepting new patients.

Expertise in
5
conditions
Dr. Brian Dawson
Family Medicine
Expertise in
5
conditions
Dr. Brian Dawson
Family Medicine

Utah Valley Instacare

395 W Cougar Blvd Ste 205, 
Provo, UT 
 (489.8 miles away)
801-357-1770
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Brian Dawson is a primary care provider, practicing in Family Medicine in Provo, Utah. Dr. Dawson is highly rated in 5 conditions, according to our data. His top areas of expertise are Osteogenesis Imperfecta, Lysinuric Protein Intolerance, Rothmund-Thomson Syndrome, and Juvenile Primary Osteoporosis. Dr. Dawson is currently accepting new patients.

Frequently Asked Questions about Dr. Shawn Searle

How do I make an appointment with Dr. Shawn Searle?

You can book an appointment with Dr. Shawn Searle by calling their office at 801-269-8200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Shawn Searle a top-rated expert for Phenylketonuria (PKU)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Shawn Searle is classified as an Advanced expert for Phenylketonuria (PKU), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Shawn Searle specialize in?

While Dr. Shawn Searle is a Family Medicine, they have specific expertise in Phenylketonuria (PKU), Alzheimer's Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Shawn Searle participate in research or clinical trials?

Yes. Dr. Shawn Searle has published 11 articles and abstracts on conditions like Phenylketonuria (PKU). You can view a list of Dr. Shawn Searle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Shawn Searle accept my insurance?

Dr. Shawn Searle accepts most major insurance plans, including Aetna. We recommend calling the office directly at 801-269-8200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Searle's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile